Neurologic Imaging

Which Imaging Study Is Best for Suspected Central Nervous System Vasculitis?

·
Which Imaging Study Is Best for Suspected Central Nervous System Vasculitis?

A 48-year-old patient presents to your clinic with a three-week history of persistent headaches, subtle cognitive slowing, and a new focal motor deficit in their left arm. Their inflammatory markers are mildly elevated, but there is no clear infectious source or history of trauma. You are concerned about an inflammatory process affecting the cerebral vasculature, and central nervous system (CNS) vasculitis is high on your differential. The immediate question is which imaging study provides the most diagnostic value without unnecessary risk. According to the American College of Radiology (ACR) Appropriateness Criteria, MRA head without IV contrast is rated Usually Appropriate as the initial imaging step in this challenging clinical scenario.

Who Fits the Clinical Scenario for Suspected CNS Vasculitis?

This imaging workflow is designed for patients presenting with new, often subacute, multifocal neurologic symptoms where CNS vasculitis is a primary consideration. The clinical picture is frequently nonspecific and can include progressive headaches, encephalopathy, seizures, or stroke-like focal deficits that do not conform to a single vascular territory. These symptoms may develop over days to weeks. This guidance applies whether the suspected vasculitis is primary (e.g., Primary Angiitis of the CNS, or PACNS) or secondary to a known or suspected systemic inflammatory condition like lupus, sarcoidosis, or giant cell arteritis.

This pathway is distinct from other cerebrovascular emergencies. It does not apply to patients who present with:

  • A “thunderclap” headache: This presentation strongly suggests a subarachnoid hemorrhage, and the workup follows a different ACR pathway, typically starting with a non-contrast head CT.
  • Known subarachnoid hemorrhage with new deficits: New deficits in this context are highly concerning for cerebral vasospasm, which has its own dedicated imaging recommendations.
  • A need for routine aneurysm screening: Patients with a family history of aneurysms or specific genetic conditions follow a separate surveillance protocol.

Correctly identifying the clinical scenario is crucial, as applying this workflow to a patient with a suspected aneurysm rupture could lead to dangerous diagnostic delays.

What Diagnoses Are You Working Up With Suspected CNS Vasculitis?

Ordering imaging for suspected CNS vasculitis aims to identify vascular abnormalities while helping to differentiate it from several important mimics. The differential diagnosis is broad, and imaging plays a key role in narrowing the possibilities.

Primary Angiitis of the Central Nervous System (PACNS) is the classic but rare diagnosis you are investigating. It is an idiopathic inflammatory condition confined to the arteries and veins of the brain and spinal cord. Imaging is essential for diagnosis, as it can reveal the characteristic segmental narrowing of multiple vessels.

Secondary CNS Vasculitis is more common than PACNS. This occurs when a systemic autoimmune disease (e.g., systemic lupus erythematosus, Behçet disease), infection (e.g., Varicella-zoster virus, tuberculosis), or malignancy leads to inflammation of the CNS vessels. The imaging findings can be identical to PACNS, but the presence of a systemic condition guides further management.

Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a critical mimic of CNS vasculitis. It is characterized by multifocal arterial constriction and dilation that typically resolves within three months. While it can present with focal deficits, it is often associated with recurrent thunderclap headaches. Distinguishing RCVS from vasculitis is paramount because the treatments are starkly different; corticosteroids, the mainstay for vasculitis, can potentially worsen RCVS.

Intracranial Atherosclerotic Disease (ICAD) can also cause multifocal stenosis and ischemic events, particularly in older patients with vascular risk factors. The location of stenosis (often at major bifurcations) and lack of inflammatory markers can help differentiate it from vasculitis, but there can be significant overlap on initial imaging.

Why Is MRA Head Without Contrast the Recommended Initial Study for CNS Vasculitis?

The ACR rates MRA head without IV contrast as Usually Appropriate because it provides an excellent, non-invasive evaluation of the intracranial arteries without exposing the patient to ionizing radiation or contrast agents.

The primary goal of initial imaging is to visualize the lumen of the medium-to-large cerebral arteries. Time-of-flight (TOF) MRA, the standard non-contrast technique, is highly effective at detecting the “beaded” appearance of alternating stenosis and ectasia that is characteristic of vasculitis. It can also identify vessel occlusions and flow abnormalities. Since MRA is a non-contrast study, it avoids the risks associated with gadolinium, such as nephrogenic systemic fibrosis in patients with renal impairment. The radiation level is O (0 mSv), making it a safe choice, especially in younger patients who may require follow-up imaging.

While MRA focuses on the vessels, a comprehensive evaluation requires assessing the brain parenchyma for the consequences of vasculitis, such as multifocal infarcts of varying ages. For this reason, MRI head without and with IV contrast and MRI head without IV contrast are also rated Usually Appropriate. In practice, the most common and effective initial order is a comprehensive brain MRI that includes standard parenchymal sequences (T1, T2, FLAIR, DWI) along with a non-contrast TOF MRA of the head.

Alternative Studies and Their Rationale:

  • CTA head with IV contrast is rated May be appropriate. While fast and widely available, it involves both ionizing radiation (RRL=☢☢☢ 1-10 mSv) and iodinated contrast. Its spatial resolution for smaller, distal vessels may be inferior to high-quality MRA or digital subtraction angiography.
  • Arteriography cervicocerebral (DSA) is also rated May be appropriate. It remains the gold standard for vessel morphology but is reserved for specific situations due to its invasive nature. DSA carries a small but significant risk of procedural stroke and involves a higher radiation dose. It is typically used when non-invasive studies are negative or equivocal but clinical suspicion for vasculitis remains high.

Once you’ve decided on the recommended study, our protocol guide covers the technical details, sequence parameters, and interpretation principles. For a deep dive into the technique, see our guide: MRA Brain Without Contrast (3D TOF).

What Is the Downstream Workflow After an Initial MRA for CNS Vasculitis?

The results of the initial MRA and MRI will guide the subsequent diagnostic and therapeutic pathway. The workflow is often complex and requires a multidisciplinary approach involving neurology, rheumatology, and radiology.

If the study is positive for vasculitis: Findings of multifocal, segmental arterial narrowing on MRA, especially when coupled with corresponding ischemic lesions on parenchymal MRI, strongly support the diagnosis. The next step is to differentiate primary from secondary vasculitis. This involves a comprehensive systemic workup, including extensive serologic testing for autoimmune and infectious causes. A lumbar puncture to analyze cerebrospinal fluid (CSF) for inflammation is almost always required. In many cases, a definitive diagnosis of PACNS requires a brain and leptomeningeal biopsy to demonstrate transmural vessel inflammation.

If the study is negative: A normal MRA and MRI significantly lower the probability of large- or medium-vessel CNS vasculitis. However, they do not entirely rule out small-vessel vasculitis, which may not be visible on conventional MRA. If clinical suspicion remains high despite negative non-invasive imaging, the next steps may include pursuing high-resolution vessel wall imaging (VWI) to look for vessel wall enhancement, a direct sign of inflammation. If VWI is unavailable or negative, conventional arteriography (DSA) may be considered to assess for more subtle abnormalities.

If the study is indeterminate or suggests a mimic: If the imaging shows diffuse vasospasm without corresponding infarcts, the diagnosis of RCVS should be strongly considered. A follow-up MRA in several weeks showing resolution of the stenosis would confirm RCVS. If findings are more consistent with ICAD (e.g., focal stenosis at the carotid terminus in a patient with hyperlipidemia), management would shift toward aggressive medical management of vascular risk factors.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for suspected CNS vasculitis is fraught with potential pitfalls. Awareness of these common errors can improve diagnostic accuracy and patient safety.

  • Over-reliance on a single negative study: A normal non-contrast MRA does not exclude small-vessel vasculitis. Persistently high clinical suspicion warrants further investigation.
  • Misinterpreting RCVS as vasculitis: This is the most critical pitfall, as administering high-dose steroids for presumed vasculitis can be detrimental in RCVS. Look for clinical clues like thunderclap headaches and a lack of significant parenchymal ischemia.
  • Forgetting the systemic workup: Never assume vasculitis is primary (PACNS) until a thorough search for secondary causes (infection, systemic autoimmune disease, malignancy) is negative.
  • Delaying brain biopsy when necessary: While invasive, biopsy remains the gold standard for diagnosing PACNS. Indefinite treatment with immunosuppressants without a tissue diagnosis carries its own significant risks.

If the non-invasive imaging is equivocal or the clinical picture is complex, escalate by consulting with a neurologist or rheumatologist with expertise in vasculitis. A neuroradiologist’s input is invaluable for interpreting subtle findings and recommending advanced techniques like vessel wall imaging.

Related ACR Topics and Tools

This article focuses on a single clinical scenario. For a comprehensive overview of imaging for other related conditions, or to explore the tools used to make these recommendations, please refer to the resources below.

Frequently Asked Questions

Why is MRA without contrast preferred over MRA with contrast for initial imaging of suspected CNS vasculitis?

For evaluating suspected CNS vasculitis, the primary goal is to visualize the vessel lumen for stenosis, which is best accomplished with non-contrast Time-of-Flight (TOF) MRA. The ACR rates MRA head with IV contrast as ‘Usually Not Appropriate’ for this initial indication because gadolinium contrast does not significantly improve the visualization of luminal narrowing in this context. Contrast is primarily used for parenchymal assessment (on T1-weighted MRI sequences) or for specific techniques like vessel wall imaging, which is typically a second-line investigation.

If the MRA is negative, is CNS vasculitis ruled out?

No. A negative conventional MRA effectively rules out large- and medium-vessel vasculitis but cannot exclude isolated small-vessel vasculitis, as the affected vessels are below the resolution of the technique. If clinical suspicion remains high despite a normal MRA, further evaluation with high-resolution vessel wall imaging (VWI), conventional angiography (DSA), or brain biopsy may be necessary.

Can CT Angiography (CTA) be used instead of MRA if MRI is not available or contraindicated?

Yes, CTA head with IV contrast is rated ‘May be appropriate’ by the ACR and can be a reasonable alternative when MRI is contraindicated (e.g., incompatible implanted device) or not immediately available. CTA is very fast and can detect stenosis in larger vessels, but it involves ionizing radiation and iodinated contrast and may have lower sensitivity for more subtle or distal vessel abnormalities compared to MRA.

What is the role of vessel wall imaging (VWI) in suspected CNS vasculitis?

Vessel wall imaging is an advanced MRI technique that directly visualizes the wall of the blood vessel, rather than just the lumen. It can detect vessel wall thickening and enhancement, which are direct signs of inflammation. While not typically a first-line test, it is becoming increasingly important in cases where conventional MRA is negative or equivocal, as it can help differentiate vasculitis from non-inflammatory mimics like RCVS or atherosclerosis.

Does the imaging approach change if I suspect Giant Cell Arteritis (GCA) is the cause of the CNS symptoms?

The initial intracranial imaging approach remains the same (MRI/MRA of the head). However, if GCA is suspected, the workup must also include imaging of the extracranial large vessels, as GCA commonly affects the aorta and its primary branches. This often involves a dedicated CTA or MRA of the neck, chest, and abdomen, in addition to the standard temporal artery biopsy.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026